Related Experiment Video
Updated: Jun 3, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
miRNAs Dysregulated in Human Papillomavirus-Associated Benign Prostatic Lesions and Prostate Cancer
Sandra Viridiana Salgado-Hernández1, Lucero Martínez-Retamoza1, Rodolfo Ocadiz-Delgado2
1Laboratorio de Biomedicina Molecular I, Programas de Doctorado en Ciencias en Biotecnología y Maestría en Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.
Chronic inflammation is linked to prostate diseases like prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa). Understanding this connection is crucial for diagnosing and treating these common male health conditions.
Area of Science:
- Urology
- Oncology
- Inflammation Research
Background:
- Prostate pathologies, including chronic prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa), are prevalent conditions affecting men's health.
- Chronic inflammation is recognized as a significant risk factor and a defining characteristic of these prostate diseases.
Purpose of the Study:
- To investigate the intricate relationship between chronic inflammation and the development and progression of prostate pathologies.
- To explore the role of inflammation as a unifying mechanism across different prostate conditions.
Main Methods:
- Review of existing literature on prostate inflammation.
- Analysis of pathological markers associated with chronic inflammation in prostate tissues.
- Correlation studies between inflammatory markers and disease severity in BPH and PCa.
Main Results:
- Consistent evidence links chronic inflammation to the pathogenesis of prostatitis, BPH, and PCa.
- Specific inflammatory pathways and mediators are identified as crucial in disease progression.
- Inflammation is shown to be a common denominator across diverse prostate pathologies.
Conclusions:
- Chronic inflammation is a critical factor in the development and exacerbation of prostate pathologies.
- Targeting inflammatory pathways presents a potential therapeutic strategy for managing prostatitis, BPH, and PCa.
- Further research into the precise mechanisms of inflammation in prostate disease is warranted.
Related Concept Videos
MicroRNAs
Abnormal Proliferation

